Keynote Chat with James P. Allison, PhD

OncLive^® is proud to announce the 9th Annual Giants of Cancer Care^® inductee ceremony will include a keynote presentation from James P. Allison, PhD. Join us for this exclusive event.

James P. Allison, PhD

The University of Texas MD Anderson Cancer Center

Dr. Allison is a Giants of Cancer Care^® alumnus who was honored with the Scientific Advances award in 2014. He has a longstanding interest in mechanisms of T cell development and activation, and the development of novel strategies for tumor immunotherapy. He was the first person to isolate the T-cell antigen and find the "brake" (ie, cytotoxic T-lymphocyte antigen 4 [CTLA-4]) that stops T-cell proliferation. Dr. Allison's research with Jedd D. Wolchok, MD, PhD (also a former inductee), in the 1990s at the University of California, Berkeley, led to the clinical development of ipilimumab (Yervoy), which was approved in 2011 by the FDA for the treatment of metastatic melanoma.

Join us as we recognize the 2021 Giants of Cancer Care^® inductees and learn what the award meant to Dr. Allison. Your presence elevates an event where Oncology’s brightest stars are honored. Attendees of the live and virtual event will receive an exclusive link allowing them to view the entire interview with Dr. Allison, following the ceremony.